Literature DB >> 11161403

Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236.

A Staratschek-Jox1, R K Thomas, T Zander, N Massoudi, M Kornacker, J Bullerdiek, C Fonatsch, V Diehl, J Wolf.   

Abstract

Hodgkin-Reed Sternberg cells are derived from germinal centre B-cells in most cases. Somatic mutations affecting their rearranged immunoglobulin genes were detected, rendering potential functional rearrangements non-functional. Under physiological conditions such cells would be designated to undergo apoptosis within the germinal centre. In search for the specific transforming event that prevents Hodgkin-Reed Sternberg cells from programmed cell death, cytogenetic analyses were broadly performed but did not reveal specific chromosomal aberrations. Analysis of these cells on the molecular level is difficult to perform due to the scarcity of the cells in the lymphoma tissue and the given limitations of in situ studies. To overcome these limitations, the cell line L1236, known to be derived from Hodgkin-Reed Sternberg cells in situ, was chosen for allelotype analysis. Using a panel of microsatellite loci assigned to nearly all chromosomal arms, regions of loss of heterozygosity were detected on chromosomal arms 6p, 9q and 17p. The size of lost segments was estimated by amplification of additional microsatellite loci mapped to the respective regions. Further analyses of single Hodgkin-Reed Sternberg cells will reveal whether LOH affecting these regions is a recurrent event in HD and to which extent the smallest commonly affected region can be estimated.

Entities:  

Mesh:

Year:  2001        PMID: 11161403      PMCID: PMC2363750          DOI: 10.1054/bjoc.2000.1593

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cells.

Authors:  U Hasse; M Tinguely; E O Leibundgut; J F Cajot; A M Garvin; A Tobler; B Borisch; M F Fey
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

2.  Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.

Authors:  P Chattopadhyay; A Rathore; M Mathur; C Sarkar; A K Mahapatra; S Sinha
Journal:  Oncogene       Date:  1997-08-14       Impact factor: 9.867

3.  Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.

Authors:  A J Keen; M A Knowles
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

4.  Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.

Authors:  S K Grebe; B McIver; I D Hay; P S Wu; L M Maciel; H A Drabkin; J R Goellner; C S Grant; R B Jenkins; N L Eberhardt
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

5.  Tumor necrosis factor-alpha allelic frequency and chromosome 6 allelic imbalance in patients with colorectal cancer.

Authors:  R Honchel; S McDonnell; D J Schaid; S N Thibodeau
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

6.  Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.

Authors:  J Wolf; U Kapp; H Bohlen; M Kornacker; C Schoch; B Stahl; S Mücke; C von Kalle; C Fonatsch; H E Schaefer; M L Hansmann; V Diehl
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

7.  Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient.

Authors:  H Kanzler; M L Hansmann; U Kapp; J Wolf; V Diehl; K Rajewsky; R Küppers
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

8.  Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease.

Authors:  K Weber-Matthiesen; J Deerberg; M Poetsch; W Grote; B Schlegelberger
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

9.  Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma.

Authors:  B Jungnickel; A Staratschek-Jox; A Bräuninger; T Spieker; J Wolf; V Diehl; M L Hansmann; K Rajewsky; R Küppers
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

10.  Polymerase chain reaction allelotyping of human ovarian cancer.

Authors:  R J Osborne; V Leech
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.